Home > Financial Ratios > EMCURE PHARMACEUTICALS

EMCURE PHARMACEUTICALS
Working Capital/Sales

    Back to All Ratios
EMCURE PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for EMCURE PHARMACEUTICALS
Please provide your vote to see the results

EMCURE PHARMACEUTICALS Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Working Capital/Sales(x) 4.256.507.4713.0220.21

What is the latest Working Capital/Sales ratio of EMCURE PHARMACEUTICALS ?

The latest Working Capital/Sales ratio of EMCURE PHARMACEUTICALS is 4.25 based on Mar2025 Consolidated results.
Year Working Capital/Sales
Mar20254.25
Mar20246.50
Mar20237.47
Mar202213.02
Mar202120.21

How is Working Capital/Sales of EMCURE PHARMACEUTICALS Trending?

Years Working Capital/Sales % Change
Mar2025 4.25
-34.62
Mar2024 6.5
-12.99
Mar2023 7.47
-42.63
Mar2022 13.02
-35.58
Mar2021 20.21 -

Other Financial Ratios of EMCURE PHARMACEUTICALS


Compare Working Capital/Sales ratio of peers of EMCURE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS ₹31,851.9 Cr 2.4% 1.6% 68.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹433,848.0 Cr 11.6% 0.7% -0.4% Stock Analytics
DIVIS LABORATORIES ₹172,697.0 Cr 2.3% 8.5% 8.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹141,859.0 Cr 1.8% -1.8% 30.7% Stock Analytics
DR REDDYS LABORATORIES ₹110,421.0 Cr 0.5% 3.2% 13.3% Stock Analytics
CIPLA ₹105,811.0 Cr 1.2% 5.4% -13.7% Stock Analytics


EMCURE PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS

2.4%

1.6%

68.6%

SENSEX

-1%

2.2%

-3.6%


You may also like the below Video Courses